Latest Insider Transactions at Mirati Therapeutics, Inc. (MRTX)
This section provides a real-time view of insider transactions for Mirati Therapeutics, Inc. (MRTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mirati Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mirati Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2021
|
Bruce L A Carter |
BUY
Grant, award, or other acquisition
|
Direct |
1,475
+29.8%
|
-
|
|
Jan 15
2021
|
Charles M Baum Founder, President, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,665
+15.5%
|
-
|
|
Jan 15
2021
|
Jamie Christensen EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,023
+11.46%
|
-
|
|
Jan 15
2021
|
Benjamin Hickey EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,023
+20.76%
|
-
|
|
Jan 15
2021
|
Vickie S Reed SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,157
+26.34%
|
-
|
|
Jan 07
2021
|
Daniel Faga EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,625
-5.0%
|
$564,375
$215.82 P/Share
|
|
Jan 07
2021
|
Benjamin Hickey EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,078
-4.75%
|
$446,770
$215.82 P/Share
|
|
Jan 07
2021
|
Vickie S Reed SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
241
-3.13%
|
$52,056
$216.33 P/Share
|
|
Jan 06
2021
|
Charles M Baum Founder, President, and CEO |
SELL
Open market or private sale
|
Direct |
4,511
-2.45%
|
$960,843
$213.02 P/Share
|
|
Jan 06
2021
|
Jamie Christensen EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,459
-1.5%
|
$310,767
$213.07 P/Share
|
|
Jan 06
2021
|
Vickie S Reed SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
538
-3.26%
|
$114,056
$212.99 P/Share
|
|
Dec 29
2020
|
Charles M Baum Founder, President, and CEO |
SELL
Bona fide gift
|
Direct |
10,000
-9.8%
|
-
|
|
Dec 18
2020
|
Charles M Baum Founder, President, and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-4.43%
|
$9,440,000
$236.47 P/Share
|
|
Dec 18
2020
|
Charles M Baum Founder, President, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+21.98%
|
$320,000
$8.49 P/Share
|
|
Dec 15
2020
|
Henry J Fuchs |
SELL
Open market or private sale
|
Direct |
10,000
-20.77%
|
$2,340,000
$234.33 P/Share
|
|
Dec 15
2020
|
Henry J Fuchs |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+45.45%
|
$200,000
$20.54 P/Share
|
|
Dec 14
2020
|
Michael G Grey |
SELL
Open market or private sale
|
Direct |
10,900
-12.8%
|
$2,670,500
$245.41 P/Share
|
|
Dec 14
2020
|
Michael G Grey |
BUY
Exercise of conversion of derivative security
|
Direct |
10,900
+41.83%
|
$174,400
$16.84 P/Share
|
|
Dec 14
2020
|
Bruce L A Carter |
SELL
Open market or private sale
|
Direct |
2,250
-9.87%
|
$551,250
$245.87 P/Share
|
|
Dec 14
2020
|
Bruce L A Carter |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+34.62%
|
$13,500
$6.78 P/Share
|
|
Nov 02
2020
|
Jamie Christensen EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,879
+7.36%
|
$119,669
$11.96 P/Share
|
|
Oct 30
2020
|
Boxer Capital, LLC |
SELL
Payment of exercise price or tax liability
|
Direct |
3
-0.0%
|
$657
$219.97 P/Share
|
|
Oct 30
2020
|
Boxer Capital, LLC |
BUY
Exercise of conversion of derivative security
|
Direct |
400,003
+14.91%
|
-
|
|
Oct 30
2020
|
Boxer Capital, LLC |
SELL
Open market or private sale
|
Direct |
400,000
-17.58%
|
$80,800,000
$202.0 P/Share
|
|
Oct 29
2020
|
Braslyn Ltd. > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
1
|
$202
$202.25 P/Share
|
|
Oct 29
2020
|
Braslyn Ltd. > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
104,565
+3.23%
|
-
|
|
Oct 29
2020
|
Braslyn Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
104,564
-0.21%
|
$22,167,568
$212.26 P/Share
|
|
Oct 28
2020
|
Braslyn Ltd. > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
2
-0.0%
|
$418
$209.16 P/Share
|
|
Oct 28
2020
|
Braslyn Ltd. > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
295,438
+8.61%
|
-
|
|
Oct 28
2020
|
Braslyn Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
295,436
-1.09%
|
$61,155,252
$207.39 P/Share
|
|
Jun 12
2020
|
Braslyn Ltd. > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
6
-0.0%
|
$432
$72.8 P/Share
|
|
Jun 12
2020
|
Braslyn Ltd. > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
600,006
+16.06%
|
-
|
|
Jun 12
2020
|
Braslyn Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-19.13%
|
$41,400,000
$69.0 P/Share
|
|
Jan 10
2020
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
50,000
+2.75%
|
$4,850,000
$97.5 P/Share
|
|
Jul 23
2019
|
Avoro Capital Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
62,500
-1.62%
|
$6,312,500
$101.88 P/Share
|
|
Jul 17
2019
|
Boxer Capital, LLC |
SELL
Open market or private sale
|
Direct |
725,008
-21.13%
|
$72,500,800
$100.88 P/Share
|
|
Jul 17
2019
|
Boxer Capital, LLC |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
725,008
+29.71%
|
-
|
|
Mar 20
2019
|
Avoro Capital Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
23,781
-0.61%
|
$1,712,232
$72.8 P/Share
|
|
Mar 19
2019
|
Avoro Capital Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
100,000
-2.51%
|
$7,300,000
$73.43 P/Share
|
|
Mar 18
2019
|
Avoro Capital Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
125,000
-3.04%
|
$9,500,000
$76.55 P/Share
|
|
Mar 01
2019
|
Braslyn Ltd. > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
4
-0.0%
|
$288
$72.8 P/Share
|
|
Mar 01
2019
|
Braslyn Ltd. > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
275,004
+8.06%
|
-
|
|
Mar 01
2019
|
Braslyn Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
275,000
-8.77%
|
$18,975,000
$69.0 P/Share
|
|
Mar 01
2019
|
Boxer Capital, LLC |
SELL
Payment of exercise price or tax liability
|
Direct |
6
-0.0%
|
$432
$72.8 P/Share
|
|
Mar 01
2019
|
Boxer Capital, LLC |
BUY
Exercise of conversion of derivative security
|
Direct |
425,006
+19.85%
|
-
|
|
Mar 01
2019
|
Boxer Capital, LLC |
SELL
Open market or private sale
|
Direct |
425,000
-24.77%
|
$29,325,000
$69.0 P/Share
|
|
Feb 20
2019
|
Avoro Capital Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
686,820
-14.31%
|
$50,137,860
$73.0 P/Share
|
|
Jan 17
2019
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
150,000
+8.04%
|
$9,300,000
$62.0 P/Share
|
|
Jan 09
2019
|
Boxer Capital, LLC |
BUY
Exercise of conversion of derivative security
|
Direct |
150,003
+8.74%
|
-
|
|
Jan 09
2019
|
Boxer Capital, LLC |
SELL
Payment of exercise price or tax liability
|
Direct |
3
-0.0%
|
$150
$50.89 P/Share
|